Financial Data and Key Metrics Changes - The company reported organic sales growth of 3% for 2025, which was below expectations due to a slowdown in the U.S. market and a weaker cold and flu season [8][9] - Gross margin improved by 220 basis points, contributing to a high single-digit operating growth at constant currency [10][44] - The company anticipates organic sales growth guidance of 3%-5% for 2026, indicating a potential sequential acceleration [6][11] Business Line Data and Key Metrics Changes - The U.S. market experienced a decline of approximately 0.5%, while APAC, EMEA, and LATAM grew in the mid-single digits [8][9] - Oral health business showed strong performance, helping to offset declines in the cold and flu category [9][20] - The company plans to focus on driving category growth through investments in advertising and promotion (A&P) and innovation [10][12] Market Data and Key Metrics Changes - Emerging markets, particularly India and China, are expected to contribute significantly to growth, with India showing double-digit growth and strong performance in oral health [29][30] - The company noted a slowdown in LATAM, particularly in Q4, due to challenging macroeconomic conditions [30][31] - E-commerce is growing aggressively in China, with significant contributions from platforms like Douyin [29][30] Company Strategy and Development Direction - The company has restructured its leadership to enhance agility and drive growth, including the creation of a Chief Growth Officer role and six operating units [15][18] - Focus on innovation and commercial execution is emphasized to improve competitiveness in the U.S. market [15][19] - The company aims to leverage its strengths in oral health and expand its reach in emerging markets [12][29] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the uncertain market conditions but expressed confidence in returning to the medium-term growth target of 4%-6% [11][68] - The company is focused on addressing consumer needs and driving category growth despite current challenges [52][53] - Management highlighted the importance of the cold and flu category for overall consumer health and its role in securing shelf space [56][57] Other Important Information - The company has increased A&P investment by over 7% compared to the previous year, with a significant portion allocated to oral health and emerging markets [35][75] - The productivity program has been successful, allowing for flexibility in investments for growth [44][46] Q&A Session Summary Question: What are the main drivers behind the organic sales growth guidance of 3%-5% for 2026? - Management indicated that the guidance reflects expected market improvements and a focus on driving category growth through investments and innovation [6][11] Question: Can you discuss the new reorganization and its impact on growth in the U.S.? - The reorganization aims to unlock growth and agility, with a focus on commercial execution and category strategies [15][18] Question: How is the performance in emerging markets, and what are the growth drivers? - Emerging markets are performing well, particularly in India and China, with a focus on volume growth and expanding reach [29][30] Question: How does the company plan to balance top-line performance with margin improvement? - Management emphasized the importance of investing in the right areas to drive sustainable growth while improving margins [35][36] Question: What is the outlook for the cold and flu business and its importance? - The cold and flu category is crucial for consumer health and shelf space, with management confident in its long-term growth potential [56][57]

Financial Data and Key Metrics Changes - Reported net revenues decreased by 3% to €760 million, with organic sales declining by 3.6% and volume declining by 3.7% [23][24] - Gross margin increased by 90 basis points year on year to 27.8% [24] - Adjusted EBITDA decreased by 1.8% year on year to €120 million, while adjusted EPS fell by 5.4% to €0.35 due to net sales contraction [26][30] Business Line Data and Key Metrics Changes - Net sales for growth platforms rose by 36% year over year in the first quarter, with chicken performing particularly well [15] - Retail sell-through was slightly positive at +0.2%, indicating that sell-in led sell-through by nearly four percentage points [23] Market Data and Key Metrics Changes - The frozen category in Europe remains healthy, with growth recently accelerating, driven by improved volume and value gains [12][13] - The category has outgrown the overall food industry by nearly one percentage point over the past decade [12] Company Strategy and Development Direction - The company is focused on long-term health by continuing to invest in brands and products despite current headwinds [11] - A new master brand advertising campaign is set to launch, emphasizing the taste appeal and nutritional profile of frozen food brands, particularly in the fish category [17] Management's Comments on Operating Environment and Future Outlook - Management acknowledged headwinds from retailer inventory destocking and increased consumer value-seeking behavior, leading to a revised outlook for organic revenue growth [10][29] - The company expects organic sales to return to growth beginning in the second quarter, with profitable growth anticipated for the remainder of the year [23][31] Other Important Information - The company repurchased €49 million of shares and paid €25 million in dividends in the first quarter, marking a 152% increase in total cash returned to shareholders compared to the previous year [9][28] - Adjusted free cash flow conversion ratio fell to 24% due to higher working capital pressures [26] Q&A Session Summary Question: Impact of retailer destocking - Management noted that destocking was broad-based across 12 to 13 countries, with greater than expected impacts [36][37] Question: Outlook for category growth - Management confirmed that the category remains healthy, with expectations for market share growth despite some softness in the UK [40][41] Question: New product innovation and consumer shifts - Management indicated that new consumers are shifting from both smaller brands and private labels, with a focus on snacking occasions [48][51] Question: Input cost increases - Input costs are primarily rising in proteins, particularly chicken and red meat, due to demand and external factors like avian flu [58] Question: Pricing strategy amidst consumer trading down - Management acknowledged that consumers are seeking value, and pricing strategies will be a combination of various factors, including advertising and product innovation [64][66]

Financial Data and Key Metrics Changes - Reported net revenues decreased by 3% to €760 million, with organic sales declining by 3.6% and volume declining by 3.7% [23][24] - Gross margin increased by 90 basis points year on year to 27.8% [24] - Adjusted EBITDA decreased by 1.8% year on year to €120 million, while adjusted EPS fell by 5.4% to €0.35 due to net sales contraction [26][29] Business Line Data and Key Metrics Changes - Net sales for growth platforms rose by 36% year over year in the first quarter, with chicken performing particularly well [14] - Retail sell-through was slightly positive at +0.2%, indicating that sell-in led sell-through by nearly four percentage points [23] Market Data and Key Metrics Changes - The frozen category in Europe remains healthy, with growth recently accelerating driven by improved volume and value gains [11][12] - The UK market is experiencing some softness, particularly in the ice cream segment, which is expected to impact margins [41][68] Company Strategy and Development Direction - The company is focused on long-term health by continuing to invest in brands and products despite current headwinds [10][30] - A new master brand advertising campaign is set to launch, emphasizing the taste appeal and nutritional profile of frozen food brands, particularly in the fish category [16] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by retailer inventory destocking and increased consumer value-seeking behavior [9][10] - The full-year organic revenue, adjusted EBITDA, and adjusted EPS growth ranges have been lowered due to these challenges [10][29] Other Important Information - The company repurchased €49 million of shares and paid €25 million in dividends in the first quarter, marking a 152% increase in total cash returned to shareholders compared to the previous year [8][28] - The company expects to achieve profitable growth for the remainder of the year despite the current headwinds [23][31] Q&A Session Summary Question: Impact of retailer destocking - Management noted that destocking was broad-based across 12 to 13 countries and various segments, with greater than expected impacts [35][37] Question: Expectations for category growth and market share - Management indicated that the category remains healthy, with expectations for growth in the next quarters and a slight recovery in market share [39][40] Question: Insights on new product innovation and consumer shifts - Management highlighted that innovations are increasingly catering to snacking occasions, attracting new consumers from both frozen and fresh categories [47][50] Question: Input cost increases - Management clarified that input cost increases are primarily related to proteins, with no significant tariff impacts currently observed [58] Question: Pricing strategy amidst consumer trading down - Management acknowledged the volatility in consumer behavior and emphasized a balanced approach to pricing, innovation, and advertising [64][66] Question: Outlook for organic growth - Management expects a combination of volume and price growth, with volume growth anticipated in the second quarter and pricing strategies to kick in later [67][69]